High-dose-rate intraoperative irradiation: current status and future directions.
Intraoperative irradiation (IORT) refers to the delivery of a single high dose of radiation therapy at the time of surgery when the tumor bed can be precisely defined and adjacent normal tissue maximally protected. It can be effectively delivered using either electrons (IOERT) or photons produced from a high-dose-rate gamma emitting radioisotope (HDR-IORT) and has been explored primarily for locally advanced or recurrent tumors at high risk for local failure despite extensive resection and full dose external beam radiation. With coordinated multidisciplinary interaction, IORT can be integrated in a combined-modality setting without undue additional toxicity. The purpose of this review will be to summarize the growing HDR-IORT experience in the treatment of various cancers, to compare its efficacy and toxicity vis a vis the IOERT data, and to discuss future trials as well as new areas of potential application.
Hu
Kenneth S
KS
Charles and Bernice Blitman Department of Radiation Oncology, Beth Israel Medical Center, and St. Lukes-Roosevelt Hospital Center, 10 Union Square East, New York, NY 10003, USA.
Enker
Warren E
WE
Harrison
Louis B
LB
D003131:Combined Modality Therapy; D005544:Forecasting; D006801:Humans; D007432:Intraoperative Period; D009369:Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D018787:Radiation Oncology / Q000639:trends